A
Ace Vision Group
Developing innovative eye laser therapeutic technologies to heal age-related eye dysfunction and restore the eye’s natural performance for more youthful vision
About Ace Vision Group
Ace Vision Group is a medical device company focused on the ophthalmology sector, specifically targeting age-related vision impairment. The company is developing a proprietary, touchless laser therapy known as Laser Scleral Microporation (LSM) to treat presbyopia, a common condition that affects the eye's ability to focus on near objects as people age.
The company's core product is a laser-based system designed for use in an office setting, offering a non-surgical therapeutic alternative. The LSM procedure aims to restore the eye's natural ability to accommodate for near vision by creating micropores in the sclera, the white part of the eye. This approach is positioned as a treatment for the root cause of the condition.
The primary clients for this technology are ophthalmic professionals and clinics. The business model appears to be centered on the development and sale of these medical devices to healthcare providers. The company is currently in the clinical research and development phase, having recently secured a significant Series B financing round to advance its technology towards commercialization.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2006
- Headquarters
- Boston, United States
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 88.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, Woman Founder, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Apr 2025 | $29M | $118M | Undisclosed | ↗ |
| EARLY VCOther financing | Jan 2022 | $14M | $56M | Undisclosed | — |
Growth signals
Latest recorded traffic for Ace Vision Group is 20 monthly website visits, down 97.3% over the last three months. Ace Vision Group's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
The Picerne Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ace Vision Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ace Vision Group’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.